/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Celldex Therapeutics Inc\n \n\n\n\n\n
Nov 20 8:23 PM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n May 22, 2008 7:01 AM EDT
\n\n \n AVANT Immunotherapeutics Announces Oral Presentation of CDX-110 at ASCO Annual Meeting - PR Newswire\n \n \n
\n\n May 21, 2008 7:01 AM EDT
\n\n \n AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License Cancer Vaccine to Pfizer - PR Newswire\n \n \n
\n\n Jan 07, 2008 7:02 AM EST
\n\n \n Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma - PR Newswire\n \n \n
\n\n Dec 07, 2007 8:00 AM EST
\n\n \n Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme - PR Newswire\n \n \n
\n
\n\n");